InSightec's tumor ablation device wins approval in China

08/1/2013 | (Boston)

InSightec has received the go-ahead in China to market its ExAblate system for use in treating patients with uterine fibroids. The device, which uses MRI-guided focused ultrasound to allow for incision-free tumor ablation, already has been approved in the U.S. for treating patients with bone tumors.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX